23.
Polymorphisms in the apolipoprotein B-100 gene contributes to normal variation in plasma lipids in 464 Danish men born in 1948
by HANSEN, P. S
Human genetics, 1993, Vol.91 (1), p.45-50
24.
Differences in apolipoprotein(a) polymorphism in West Greenland Eskimos and Caucasian Danes
by KLAUSEN, C
Human genetics, 1992, Vol.89 (4), p.384-388
25.
Scandinavian simvastatin study (4S)
by Wright, RobertA
The Lancet (British edition), 1994, Vol.344 (8939), p.1765-1768
26.
Lipoprotein(a) and Oxygen Free Radicals in Survivors of Acute Myocardial Infarction: Effects of Captopril
by Søgaard, Peter
Cardiology, 1996, Vol.87 (1), p.18-22
27.
Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol
by Vigholt-Sørensen, E
British Heart Journal, 1990-09, Vol.64 (3), p.186-189
28.
A PvuII polymorphism of the low density lipoprotein receptor gene is not associated with plasma concentrations of low density lipoproteins including LP(a)
by KLAUSEN, I. C
Human genetics, 1993, Vol.91 (2), p.193-195
29.
Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension
by Ott, Peter
The American journal of cardiology, 1987, Vol.59 (14), p.G73-G77
30.
Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study
by Sorensen, E V
Cardiovascular drugs and therapy, 1989-04, Vol.3 (2), p.203-209
31.
ANTI-PLATELET DRUGS AND PORTACAVAL ANASTOMOSIS FOR HOMOZYGOUS HYPERCHOLESTEROLÆMIA
by Faergeman, Ole
The Lancet (British edition), 1976, Vol.308 (8000), p.1416-1416
32.
Placebo-Controlled Comparison of Captopril, Metoprolol, and Hydrochlorothiazide Therapy in Non - Insulin-Dependent Diabetic Patients With Primary Hypertension
by Gall, Mari-Anne
American journal of hypertension, 1992-05, Vol.5 (5-Pt-1), p.257-265
